During the past decade, The Second Affiliated Hospital of Soochow University conducted 72 clinical trials. In the 10-year time frame, 72 clinical trials started and 7 clinical trials were completed, i.e. on average, 9.7% percent of trials that started reached the finish line to date. In the past 5 years, 47 clinical trials started and 4 clinical trials were completed. i.e. 8.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Second Affiliated Hospital of Soochow University" #1 sponsor was "Second Affiliated Hospital of Soochow University" with 14 trials, followed by "Pfizer" with 5 trials sponsored, "BeiGene" with 4 trials sponsored, "Eli Lilly and Company" with 4 trials sponsored and "Ipsen" with 4 trials sponsored. Other sponsors include 56 different institutions and companies that sponsored additional 52 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Second Affiliated Hospital of Soochow University" #1 collaborator was "Second Affiliated Hospital of Suzhou University" with 4 trials as a collaborator, "Astellas Pharma Inc" with 3 trials as a collaborator, "The First Hospital of Jilin University" with 3 trials as a collaborator, "Affiliated Hospital of Nantong University" with 2 trials as a collaborator and "Baotou Central Hospital" with 2 trials as a collaborator. Other collaborators include 132 different institutions and companies that were collaborators in the rest 133 trials.

According to Clinical.Site data, the most researched conditions in "The Second Affiliated Hospital of Soochow University" are "Chronic Heart Failure" (3 trials), "Parkinson Disease" (3 trials), "Transient Ischemic Attack" (3 trials), "Acute Stroke" (2 trials) and "Breast Cancer" (2 trials). Many other conditions were trialed in "The Second Affiliated Hospital of Soochow University" in a lesser frequency.

Most popular intervention types in "The Second Affiliated Hospital of Soochow University" are "Drug" (71 trials), "Other" (7 trials), "Procedure" (7 trials), "Device" (6 trials) and "Biological" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "placebo" (4 trials), "Cyclophosphamide" (3 trials), "Rituximab" (3 trials) and "Tislelizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "The Second Affiliated Hospital of Soochow University" are 75 trials for "All" genders, 11 trials for "Male" genders and 5 trials for "Female" genders.

Currently, there are 42 active trials in "The Second Affiliated Hospital of Soochow University". 5 are not yet recruiting, 26 are recruiting, 9 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 24 completed trials in The Second Affiliated Hospital of Soochow University, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in The Second Affiliated Hospital of Soochow University, 5 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 10 trials that are defined as “Not Applicable".